Casing, Villano G.
HRN: 22-07-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/21/2022
10/27/2022
IVT
4.5g
Q6
Sepsis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Febrile Neutropenia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes